Study on Lipid Profile Changes in Plasma and Intestinal Mucosa of Patients With Inflammatory Bowel Disease
- Sponsor
- First Affiliated Hospital of Harbin Medical University
- Study ID
- NCT06680076
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Inflammatory Bowel Diseases
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Accepted
Study Details
This study aimed to demonstrate the characteristic lipid profile changes in patients with inflammatory bowel disease.
Key Dates
- First listed
- Nov 8, 2024
- Start date
- Dec 31, 2024
- Status verified
- Nov 2024
- Primary completion
- Feb 25, 2025
- Completion
- Mar 30, 2025
Study Design
- Enrollment
- 90 participants (estimated)
Arms
- Arm: Disease groupPatients who have inflammation bowel disease.
- Arm: Health groupHealthy people who volunteered to participate.
Primary Outcome Measure
Differential lipid composition between disease and healthy groups [ Time Frame: 14 weeks ]
Central Contacts
- Huichao Zhang, MD13945003159
Related Studies
- The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic TestingRecruiting · University of Chicago · Chicago, Illinois
- Improving the Quality of Care for Adults With Inflammatory Bowel DiseaseEnrolling By Invitation · Dartmouth-Hitchcock Medical Center · Los Angeles, California
- CorEvitas Inflammatory Bowel Disease (IBD) RegistryEnrolling By Invitation · CorEvitas · Waltham, Massachusetts
- Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy and Transplantation (The PREDICT Trial)Enrolling By Invitation · Boston Children's Hospital · Boston, Massachusetts